The new RAREFIND #MSCA-COFUND PhD Program offers a unique opportunity to dive into cutting-edge #genetherapy and #celltherapy research with top-tier, interdisciplinary training across 22 leading labs at TIGEM and SR-Tiget.
The new RAREFIND #MSCA-COFUND PhD Program offers a unique opportunity to dive into cutting-edge #genetherapy and #celltherapy research with top-tier, interdisciplinary training across 22 leading labs at TIGEM and SR-Tiget.
RAREFIND #MSCA-COFUND #PhD Programme opens its call for applications!
👉Know more and apply now: www.rarefind-cofund.eu
#RAREFINDPhD
RAREFIND #MSCA-COFUND #PhD Programme opens its call for applications!
👉Know more and apply now: www.rarefind-cofund.eu
#RAREFINDPhD
We're looking for exceptional scientists to join #TIGEM and #SR-Tiget, two world-class research centers at the forefront of innovation in #genetherapy, #celltherapy, #geneediting, #genomics, and #molecularmedicine.
We're looking for exceptional scientists to join #TIGEM and #SR-Tiget, two world-class research centers at the forefront of innovation in #genetherapy, #celltherapy, #geneediting, #genomics, and #molecularmedicine.
TIGEM was pleased to take part in the ASGCT Conference 2025, where we had the opportunity to present our latest research and engage with the gene and cell therapy community!
@asgct.bsky.social
TIGEM was pleased to take part in the ASGCT Conference 2025, where we had the opportunity to present our latest research and engage with the gene and cell therapy community!
@asgct.bsky.social
Don’t miss this Scientific Symposium hosted by the Coalition of International Gene Therapy Societies:
📌 Clinical Trials Around the Globe
🗓️ [Today, May 16th]
🕗 8:00 AM – 9:45 AM
📍 Room 293–296
#GeneTherapy #ASGCT #AAV #Retina #LiverGeneTherapy #RareDisease
Don’t miss this Scientific Symposium hosted by the Coalition of International Gene Therapy Societies:
📌 Clinical Trials Around the Globe
🗓️ [Today, May 16th]
🕗 8:00 AM – 9:45 AM
📍 Room 293–296
#GeneTherapy #ASGCT #AAV #Retina #LiverGeneTherapy #RareDisease
At TIGEM, we stand with patients — especially those with MPS VI (Maroteaux-Lamy syndrome), a rare lysosomal disorder caused by ARSB gene mutations.
At TIGEM, we stand with patients — especially those with MPS VI (Maroteaux-Lamy syndrome), a rare lysosomal disorder caused by ARSB gene mutations.
We have 2 open positions at TIGEM in the PhD program in Systems Medicine.
Deadline: June 9th – don’t miss it!
Apply here: www.semm.it/education/ho...
#PhD #SystemsMedicine #TIGEM #SEMM #PhDOpportunity #BiomedicalResearch #CallForApplications
We have 2 open positions at TIGEM in the PhD program in Systems Medicine.
Deadline: June 9th – don’t miss it!
Apply here: www.semm.it/education/ho...
#PhD #SystemsMedicine #TIGEM #SEMM #PhDOpportunity #BiomedicalResearch #CallForApplications
Meet top experts, including @diegodibi.bsky.social, Genomic Medicine Program Coordinator at TIGEM and part of this year’s Organizing Committee.
Meet top experts, including @diegodibi.bsky.social, Genomic Medicine Program Coordinator at TIGEM and part of this year’s Organizing Committee.
Read the full story here: www.tigem.it/newsroom/new...
Read the full story here: www.tigem.it/newsroom/new...
After working at #KTH (Stockholm), he’s now a Staff Scientist at TIGEM, using AI and physics-based models to design hyperactive enzymes that improve gene therapy for rare diseases.
After working at #KTH (Stockholm), he’s now a Staff Scientist at TIGEM, using AI and physics-based models to design hyperactive enzymes that improve gene therapy for rare diseases.
🔬 Exciting findings from Galietta's group, published in #JPhysiology!
This study uncovers how the apical mucus layer alters drug efficacy in the airway epithelium, impacting CFTR inhibition in cystic fibrosis research.
📖Read here: physoc.onlinelibrary.wiley.com/doi/full/10....
🔬 Exciting findings from Galietta's group, published in #JPhysiology!
This study uncovers how the apical mucus layer alters drug efficacy in the airway epithelium, impacting CFTR inhibition in cystic fibrosis research.
📖Read here: physoc.onlinelibrary.wiley.com/doi/full/10....
🔬 We are thrilled to share a groundbreaking study by De Matteis’s group, published in #LifeScienceAlliance, which uncovers a crucial link between mitochondrial dysfunction and protein aggregation in ALS8.
📖Read the article here: www.life-science-alliance.org/content/8/4/...
🔬 We are thrilled to share a groundbreaking study by De Matteis’s group, published in #LifeScienceAlliance, which uncovers a crucial link between mitochondrial dysfunction and protein aggregation in ALS8.
📖Read the article here: www.life-science-alliance.org/content/8/4/...
Our mission is to push scientific boundaries through cutting-edge research, innovative therapies, and training the next generation of biomedical experts.
Learn more: www.tigem.it
✨ #Genetics #RareDiseases #MedicalResearch
Our mission is to push scientific boundaries through cutting-edge research, innovative therapies, and training the next generation of biomedical experts.
Learn more: www.tigem.it
✨ #Genetics #RareDiseases #MedicalResearch